Vivani Medical (VANI) Emerging Growth Conference Summary
Vivani Medical presented at the Emerging Growth Conference, highlighting a new agreement with Novo Nordisk for its semaglutide implant and preparing to initiate the SLIM-1 clinical trial in August. The implant offers infrequent administration, steady drug release, and addresses adherence challenges in obesity treatment, …